Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

A case of deep vein thrombosis after coronary angiography in a patient using antidepressants and anxiolytics.

Min SY, Shin JH, Lee SW, Doo E, Kim BK, Won YW, Park HC, Choi SI, Kim SG.

Korean Circ J. 2013 Feb;43(2):132-4. doi: 10.4070/kcj.2013.43.2.132. Epub 2013 Feb 28.

2.

Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.

Liem TK, Huynh TM, Moseley SE, Minjarez RC, Landry GJ, Mitchell EL, Deloughery TG, Moneta GL.

J Vasc Surg. 2010 Sep;52(3):651-7. doi: 10.1016/j.jvs.2010.04.029. Epub 2010 Jun 16.

3.

Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.

Galanaud JP, Bosson JL, Genty C, Presles E, Cucherat M, Sevestre MA, Quere I, Decousus H, Leizorovicz A.

J Thromb Haemost. 2012 Jun;10(6):1004-11. doi: 10.1111/j.1538-7836.2012.04704.x.

4.

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.

Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS.

Arch Intern Med. 2000 Dec 11-25;160(22):3431-6.

PMID:
11112236
5.

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.

6.

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.

Circulation. 2001 May 22;103(20):2453-60.

7.
8.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
9.

The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.

Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P.

Ann Intern Med. 2007 Dec 4;147(11):766-74.

PMID:
18056660
10.

[Optimizing history taking for evaluating the risk of venous thromboembolism: the OPTIMEV study].

Sevestre MA, Labarere J, Brin S, Carpentier P, Constans J, Degeilh M, Deslandes B, Elgrishi I, Lanoye P, Laroche JP, Le Roux P, Pichot O, Quéré I, Bosson JL; OPTIMEV study.

J Mal Vasc. 2005 Sep;30(4 Pt 1):217-27. French.

PMID:
16292199
12.

Diagnosis and initial treatment of venous thromboembolism in patients with cancer.

Streiff MB.

J Clin Oncol. 2009 Oct 10;27(29):4889-94. doi: 10.1200/JCO.2009.23.5788. Epub 2009 Sep 8. Review.

PMID:
19738109
13.

Oral anticoagulant therapy in venous thromboembolism.

Cosmi B, Palareti G.

Semin Vasc Med. 2003 Aug;3(3):303-14. Review.

PMID:
15199464
14.

Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy.

Gherman RB, Goodwin TM, Leung B, Byrne JD, Montoro M.

Prim Care Update Ob Gyns. 1998 Jul 1;5(4):155-156.

PMID:
10838289
15.

Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients.

Galanaud JP, Quenet S, Rivron-Guillot K, Quere I, Sanchez Muñoz-Torrero JF, Tolosa C, Monreal M; RIETE INVESTIGATORS.

J Thromb Haemost. 2009 Dec;7(12):2028-34. doi: 10.1111/j.1538-7836.2009.03629.x. Epub 2009 Sep 28.

16.

Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.

Cook D, Attia J, Weaver B, McDonald E, Meade M, Crowther M.

J Crit Care. 2000 Dec;15(4):127-32.

PMID:
11138871
17.

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd.

Arch Intern Med. 1999 Mar 8;159(5):445-53.

PMID:
10074952
18.

Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow.

McColl MD, Tait RC, Greer IA, Walker ID.

Br J Haematol. 2001 Mar;112(3):641-3.

PMID:
11260066
19.

The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism.

Di Minno G, Mannucci PM, Tufano A, Palareti G, Moia M, Baccaglini U, Rudelli G, Giudici GA; First Ambulatory Screening On Thromboembolism (fast) Study Group.

J Thromb Haemost. 2005 Jul;3(7):1459-66.

20.

Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model.

Vink R, Kraaijenhagen RA, Levi M, Büller HR.

J Thromb Haemost. 2003 Dec;1(12):2523-30.

Supplemental Content

Support Center